DMTr-TNA-G (O6-CONPh2) (N2Ac) -amidite
DMTr-TNA-G (O6-CONPh2) (N2Ac) -amidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
325683-97-4
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dmtr-tna-g-o6-conph2-n2ac-amidite.html
Purity
98.20
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C54H57N8O9P
Molecular Weight
993.05
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MART-1 / Melan-A (M2-7C10), CF647 conjugate, 0.1mg/mL
IgA Secretory Component (SC05), CF488A conjugate, 0.1mg/mL
CD50 / ICAM3 (CG106), CF405S conjugate, 0.1mg/mL
IgA Secretory Component (SC05), CF640R conjugate, 0.1mg/mL
